# Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance

> **NCT06202911** · PHASE4 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 100 (estimated)

## Conditions studied

- Preterm Neonates and Feeding Intolerance
- Necrotizing Enterocolitis
- Oral N-acetyl Cysteine

## Interventions

- **DRUG:** oral n-acetyl cysteine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT06202911
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06202911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06202911, "Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06202911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*